Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LeLeDys: Levetiracetam for Levodopa-induced Dyskinesias in Parkinson's Disease
NCT00307450Phase 4Completed
- Sponsor
- Technische Universität Dresden
- Start
- Mar 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levetiracetam in Parkinson's disease (PD), sponsored by Technische Universität Dresden. Primary endpoint: Modified Abnormal Involuntary Movement Scale at 11 weeks. Started Mar 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00307450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307450.